Literature DB >> 30879992

Normal and fibrotic liver parenchyma respond differently to irreversible electroporation.

Chenang Lyu1, Maya Lopez-Ichikawa2, Boris Rubinsky1, Tammy T Chang3.   

Abstract

BACKGROUND: The safety and efficacy of irreversible electroporation (IRE) in treating hepatic, biliary, and pancreatic malignancies are active areas of clinical investigation. In addition, recent studies have shown that IRE may enable regenerative surgery and in vivo tissue engineering. To use IRE effectively in these clinical applications, it is important to understand how different tissue microenvironments impact the response to IRE. In this study, we characterize the electrical and histological properties of non-fibrotic and fibrotic liver parenchyma before and after IRE treatment.
METHODS: Electrical resistivity and histology of fibrotic liver from C57BL/6 mice fed a 0.1% 3,5-diethylcarbonyl-1,4-dihydrocollidine (DDC) diet were compared to those of non-fibrotic liver from matched control mice before and after IRE treatment.
RESULTS: At baseline, the electrical resistivity of fibrotic liver was lower than that of non-fibrotic liver. Post-IRE, resistivity of non-fibrotic liver declined and then recovered back to baseline with time, correlating with hepatocyte repopulation of the ablated parenchyma without deposition of fibrotic scar. In contrast, resistivity of fibrotic liver remained depressed after IRE treatment, correlating with persistent inflammation.
CONCLUSION: Non-fibrotic and fibrotic liver respond to IRE differently. The underlying tissue microenvironment is an important modifying factor to consider when designing IRE protocols for tissue ablation.
Copyright © 2019 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Year:  2019        PMID: 30879992      PMCID: PMC7170179          DOI: 10.1016/j.hpb.2019.01.019

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  43 in total

1.  Tissue ablation with irreversible electroporation.

Authors:  R V Davalos; I L M Mir; B Rubinsky
Journal:  Ann Biomed Eng       Date:  2005-02       Impact factor: 3.934

2.  In vivo electrical impedance measurements during and after electroporation of rat liver.

Authors:  Antoni Ivorra; Boris Rubinsky
Journal:  Bioelectrochemistry       Date:  2006-10-21       Impact factor: 5.373

3.  Effect of cell size and shape on single-cell electroporation.

Authors:  Aparna Agarwal; Imants Zudans; Emily A Weber; Jessica Olofsson; Owe Orwar; Stephen G Weber
Journal:  Anal Chem       Date:  2007-04-20       Impact factor: 6.986

4.  Lower incidence of hepatic metastases of colorectal cancer in patients with chronic liver diseases: meta-analysis.

Authors:  Goran Augustin; Tomislav Bruketa; Dragan Korolija; Milan Milosevic
Journal:  Hepatogastroenterology       Date:  2013 Jul-Aug

5.  Irreversible electroporation in locally advanced pancreatic cancer: A call for standardization of energy delivery.

Authors:  Robert C G Martin; Alan North Durham; Marc G Besselink; David Iannitti; Matthew J Weiss; Christopher L Wolfgang; Kai-Wen Huang
Journal:  J Surg Oncol       Date:  2016-08-21       Impact factor: 3.454

6.  Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment.

Authors:  Mao Lin; Shuzhen Liang; Xiaohua Wang; Yinqing Liang; Mingjie Zhang; Jibing Chen; Lizhi Niu; Kecheng Xu
Journal:  J Cancer Res Clin Oncol       Date:  2017-09-04       Impact factor: 4.553

7.  Safety and Efficacy of Irreversible Electroporation for the Treatment of Hepatocellular Carcinoma Not Amenable to Thermal Ablation Techniques: A Retrospective Single-Center Case Series.

Authors:  Olivier Sutter; Joyce Calvo; Gisèle N'Kontchou; Jean-Charles Nault; Raffik Ourabia; Pierre Nahon; Nathalie Ganne-Carrié; Valérie Bourcier; Nora Zentar; Fatna Bouhafs; Nicolas Sellier; Abou Diallo; Olivier Seror
Journal:  Radiology       Date:  2017-04-28       Impact factor: 11.105

8.  Irreversible electroporation therapy in the liver: longitudinal efficacy studies in a rat model of hepatocellular carcinoma.

Authors:  Yang Guo; Yue Zhang; Rachel Klein; Grace M Nijm; Alan V Sahakian; Reed A Omary; Guang-Yu Yang; Andrew C Larson
Journal:  Cancer Res       Date:  2010-02-02       Impact factor: 12.701

9.  The effect of irreversible electroporation on blood vessels.

Authors:  Elad Maor; Antoni Ivorra; Jonathan Leor; Boris Rubinsky
Journal:  Technol Cancer Res Treat       Date:  2007-08

10.  Predicting irreversible electroporation-induced tissue damage by means of magnetic resonance electrical impedance tomography.

Authors:  Matej Kranjc; Simona Kranjc; Franci Bajd; Gregor Serša; Igor Serša; Damijan Miklavčič
Journal:  Sci Rep       Date:  2017-09-04       Impact factor: 4.379

View more
  1 in total

1.  Neutrophils are important for the development of pro-reparative macrophages after irreversible electroporation of the liver in mice.

Authors:  Maya Lopez-Ichikawa; Ngan K Vu; Amar Nijagal; Boris Rubinsky; Tammy T Chang
Journal:  Sci Rep       Date:  2021-07-22       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.